glp-1/gip/gcg receptor agonist Why does GLP‐1 combined with GIP and/or GCG agonist have greater weight loss effect than GLP‐1 agonist alone in obese adults without type 2 diabetes? - Jiang - 2025 Potential of a glucagon‐like peptide‐1

How These Agonists Support Metabolic Health By mimicking or stimulating GLP-1 activity naturally, these agonists help regulate blood sugar, reduce appetite, and promote weight loss benefits without the side effects associated with synthetic medications

(HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agonist designed for once-monthly subcutaneous dosing in obesity treatment.

Preclinical studies suggest that GIPR antagonism helps with weight loss and metabolic improvements

The year delivered progress across clinical evidence, policy, and changing market dimensions, reinforcing obesity as a chronic disease requiring structured, long-term management

While most of the recent fanfare has been related to their ro...